Mitosis-Karyorrhexis Index

Known as: MKI 
A tumor cell proliferation measurement represented by the number of cells in mitosis plus the number of cells in karyorrhexis per 5000 cells.

Topic mentions per year

Topic mentions per year

1969-2018
051019692018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The multi-kinase inhibitor (MKI) sorafenib can be an effective palliative therapy for patients with hepatocellular carcinoma (HCC… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Solute carrier (SLC) transporters regulate the cellular influx and disposition of endogenous and xenobiotic compounds, including… (More)
Is this relevant?
2010
2010
PURPOSE Multikinase inhibitor (MKI) is a promising drug for treatment of metastatic renal cell carcinoma (mRCC). We explained the… (More)
Is this relevant?
2005
2005
BACKGROUND Understanding the myocardial inflammatory response to ischemia is an important part of achieving the elusive clinical… (More)
Is this relevant?
2003
2003
OBJECTIVE To determine the reliability, validity, and responsiveness of the modified Kapandji index (MKI). DESIGN Prospective… (More)
Is this relevant?
2002
2002
Primary melanoma (MM) could be a good model to test an intuitive concept: a cancer that is growing fast in its early phase is… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND The International Neuroblastoma Pathology Classification was established in 1999 for the prognostic evaluation of… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
1995
1995
The effects of surface finish on flexural strength of a feldspathic porcelain, aluminous porcelain, and a computer aided design… (More)
Is this relevant?
Highly Cited
1984
Highly Cited
1984
Histopathologic prognostic factors of 295 pretreatment tumors of a total 641 neuroblastomas and ganglioneuroblastomas were… (More)
Is this relevant?